Physicians Interactive becomes Aptus Health, offering a global digital health engagement solution
November 19, 2015Medical Communications
Physicians Interactive has announced that it has become Aptus Health, reflecting its mission of advancing health engagement and its role …
NICE decision restricts Bayer’s Xofigo to select prostate cancer patients
November 19, 2015Research and Development, Sales and Marketing Bayer, NICE, prostate cancer
NICE has issued its Final Appraisal Determination (FAD) recommending Bayer’s Xofigo (radium-223 dichloride) for use on the NHS in England …
FDA grants Merck and Pfizer priority review for PD-L1 cell treatment
November 19, 2015The FDA has granted Merck and Pfizer’s avelumab Breakthrough Therapy Designation for the treatment of patients with metastatic merkel cell …
Merck criticises NICE ‘no’ to personalised bowel cancer drugs
November 19, 2015Research and Development
NICE has issued preliminary not recommending two specific personalised treatments used in combination with chemotherapy for previously untreated metastatic colorectal …
Merck KGaA completes $17bn Sigma-Aldrich acquisition
November 18, 2015Manufacturing and Production, Sales and Marketing M&A Sigma Aldridge, Merck, acquisitions, mergers
Merck KGaA has announced the completion of its $17 billion acquisition of Sigma-Aldrich, having cleared the final regulatory hurdle and …
Obama FDA commissioner nominee Califf defends big pharma ties
November 18, 2015Sales and Marketing Bernie Sanders, FDA, FDA commissioner, Robert Califf
President Obama’s nominee to head the FDA was forced to defend his history of ties to the pharma industry as …
Raising Awareness: World COPD Day
November 18, 2015Medical Communications COPD, COPD disease, COPD exacerbation, Synergy Vision, disease awareness, medical communications
World COPD Day 18th November 2015
NICE rejects Amgen’s Repatha in draft guidance
November 18, 2015Research and Development, Sales and Marketing Amgen, NICE, Repatha, evolocumab, high cholesterol
NICE has published draft guidance rejecting Amgen’s Repatha as a treatment for people with high cholesterol.
Challenges in oncology R&D
November 18, 2015Manufacturing and Production, Research and Development Dixie-Lee Esseltine, Takeda, Takeda oncology, Velcade, multiple myeloma, oncology
Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …
FDA accepts regulatory submission for Novartis biosimilar
November 18, 2015Research and Development, Sales and Marketing Neulasta, Novartis, Sandoz, biosimilar, pegfilgrastim
Novartis’ generics unit Sandoz has announced it has had its Biologics License Application (BLA) for a proposed biosimilar to Amgen’s …
Global drug spending will rise 30% by 2020, to $1.4 trillion
November 18, 2015Research and Development IMS Health, OTC, drug spending, emerging markets, generics, prescribing
Global spending on drugs will increase 30% to $1.4 trillion by 2020, as more patients get access to treatments and …
Scientists make possible pancreatic cancer discovery
November 18, 2015Research and Development Pancreatic cancer
Cancer researchers say they have discovered a potential new method of treatment for pancreatic cancer that could improve survival rates. …
UCB appoints Steve Turley as MD for Britain and Ireland
November 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB
Steve Turley has joined UCB as the company’s managing director for the British and Irish isles, moving from Lundbeck. He …
Norgine opens new £4.5 million warehouse
November 17, 2015Manufacturing and Production, Research and Development Norgine, Temperature control, Wales, manufacturing, production, temperature-control
Norgine has opened a new £4.5 million temperature controlled warehouse on its current site in Hengoed, Wales. The Dutch-based firm …
Crescendo Biologics appoints Dr Kevin Johnson as chairman
November 17, 2015Research and Development
Crescendo Biologics, the drug discovery and developer of Humabody VH therapeutics, has announced the appointment of Dr Kevin Johnson as non-executive …
Catalent forced to suspend production after possible employee product sabotage
November 17, 2015Manufacturing and Production
Catalent has been forced to halt production at one of its French softgel capsule factories after the US-based manufacturer identified …
AbbVie rules out joining the biosimilars bandwagon
November 17, 2015Manufacturing and Production, Research and Development
AbbVie says it has ruled out moving into the biosimilars market to stave off competition once its blockbuster drug Humira …
FDA approves ‘first of its kind’ blood cancer drug
November 17, 2015Manufacturing and Production, Research and Development
The FDA has approved Genmab’s drug Darzalex for patients with multiple myeloma. Darzalex (daratumumab) is the first human CD38 monoclonal antibody …
DJM PAN Unlimited adds client services director
November 17, 2015Manufacturing and Production, Sales and Marketing
Wyndham Clark has joined the board of DJM PAN Unlimited as client services director. Previously, Clark was client services director …
NICE rejects Roche’s Kadcyla for NHS; price still too high
November 17, 2015Manufacturing and Production, Sales and Marketing Cancer Drugs Fund, Kadcyla, NHS England, NICE, Roche
NICE has published final draft guidance on Roche’s Kadcyla as a breast cancer treatment, deciding that the drug’s price remains …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
